Therefore, by analyzing bioinformatics data and conducting cell experiments, we explored whether LYRM4-AS1 is related to worse outcomes, and the involved mechanisms of LYRM4-AS1 in glioma had also been investigated. Here, LYRM4 is linked to central nervous system cancer.